Furthermore, since serum creatinine and cystatin C are commonly employed in clinical settings for evaluating renal function, the performance of the CCR and SI to predict sarcopenia was also investigated in patients with or without chronic kidney disease (CKD). This evidence concerns the gene CST3 and chronic kidney disease.